News
-
-
-
-
PRESS RELEASE
aap Implantate AG: Full admission of all previously unadmitted shares, introduction to stock exchange trading and termination of lock-up agreements
aap Implantate AG announces full admission of previously unadmitted shares to the Frankfurt Stock Exchange's regulated market, along with the termination of lock-up agreements -
-
PRESS RELEASE
aap Implantate AG publishes final audited consolidated financial statements 2024 - confirmation of strong operational improvement
aap Implantate AG publishes final audited consolidated financial statements 2024, confirming strong operational improvement. The company achieved a significant increase in Group EBITDA -
-
PRESS RELEASE
aap Implantate AG closes financial year 2024 successfully - positive developments despite challenging environment
aap Implantate AG successfully closes financial year 2024 with positive developments, achieving sales growth and strengthening market position, especially in EMEA and LATAM regions -
-
PRESS RELEASE
EQS-Adhoc: aap Implantate AG: Company EBITDA for fiscal year 2024 at EUR –0.85 million; postponement of publication of consolidated financial statements
aap Implantate AG reports Company EBITDA of EUR -0.85 million for fiscal year 2024, leading to the postponement of consolidated financial statements publication. Analysts review impact
